Category 2022
1H
2022
2H
2023
1H
2023
2H
2024
1H
2024
2H
Target indication
BRIXELLE-INFLA
Acute inflammatory
disease
IV
CMC, PK & Tox
IND Sub.
Phase I
Phase II
Ischemic Reperfusion Injury(Organ Transplant, AKI, AMI, CABG, Stroke)
Chronic inflammatory
disease
SC/PO
Efficacy & MoA
Formulation dev.
PK & Tox
TBD
(MS, IBD, Asthma, etc.)
Skin
disease
Topical
Efficacy & MoA
Formulation dev.
PK & Tox
Atopic dermatitis, Psoriasis, etc.
BRIXELLE-ONCO
Drug delivery system IV
DDS characterization
Efficacy & MoA
Formulation dev.
PK & Tox
Cancer
Discovery projects
Discovery
projects
Project A
Discovery
Efficacy & MoA
TBD
Project B
Discovery
Efficacy
TBD
Project C
Discovery
TBD

If you are interested in our pipeline, please contact us.